Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin Limited | 21/08/2023 | By Sudeep Soparkar | 317
Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin Limited | 14/08/2023 | By Sudeep Soparkar | 428
Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
Lupin Limited | 24/07/2023 | By Sudeep Soparkar | 342
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Limited | 18/07/2023 | By Sudeep Soparkar | 314
Lupin receives approval from U.S. FDA for Diazepam Rectal Gel
Global pharma major Lupin Limited (Lupin) today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA)
Lupin Limited | 02/06/2023 | By Sudeep Soparkar | 349
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy